Consulting services

Amigdala Boston supports international healthtech and biotech innovators in their U.S. soft-landing process, providing end-to-end guidance on regulatory pathways, reimbursement strategy, clinical validation partnerships, pilot implementation with healthcare providers, and the adaptation of technology platforms to the operational and data requirements of the U.S. healthcare market.

Entrepreneurial Programs for Academic Institutions

Design and implementation of entrepreneurship and innovation programs for universities, research institutes, and academic ecosystems, including venture-building curricula, startup acceleration tracks, translational research commercialization pathways, and international innovation immersion experiences connecting academic founders with the U.S. venture ecosystem.

Data and AI Strategy for Healthcare Innovation

Strategic advisory on the design and deployment of data-driven healthcare solutions, including clinical analytics architecture, AI-enabled patient stratification models, real-world evidence generation, and scalable digital health platforms aligned with value-based care models.

U.S. Soft-Landing for Healthtech and Biotech Companies

End-to-end support for international healthtech and biotech innovators entering the U.S. market, including regulatory pathway assessment, reimbursement positioning, pilot design with healthcare systems, strategic partnerships with research institutions, and operational adaptation to U.S. clinical and data environments.